Atrial Fibrillation, Gerontology
Conditions
Keywords
anticoagulant
Brief summary
Atrial fibrillation (AF) is a rhythmic cardiac activity disorder disturbing hemodynamic blood flow. It is a public health problem with 600,000 to 1 million people involved in France which 2/3 are aged over 75 years. a FA untreated exposes the patient to a significant risk of embolism responsible for a rate stroke (stroke) ischemic estimated at 85%. The anticoagulant standard treatment helps prevent the occurrence of this complication. However, oral anticoagulation also exposes patients to an increased risk of bleeding. The bleeding risk can be assessed using scales: several being proposed (HEMORR2HAGES, HAS-BLED, ATRIA and scores Shireman and Charlson ...). moreover, in geriatric hospital care, every patient has a standardized geriatric assessment to assess and quantify functional capacity, autonomy, cognitive abilities, nutritional status, psychological state and its environment social. Thus, the objective of the investigators study was to determine the frequency of each item of each bleeding risk assessment score and geriatric assessment in patients 80 and older hospitalized geriatric ward in the department and with anticoagulant.
Interventions
OTHERquestionnaires
scales : HEMORR2HAGES (hepatics diseases, alcoholism, cancer, thrombocytopenia, anemia and antecedent...), HAS-Bled (arterial hypertension, renal function, liver function, cerebrovascular accident...), ATRIA (anemia, serious kidney diseases, hypertension, antecedent...), Shireman (gender, age, hemorrhage, diabetes, anemia...), Charlson (age, cardiovascular disease, lung disease, neurological disease, endocrinal disease, nephrology, liver disease, gastroenterology, cancer) and standardised geriatric assessment (comorbidities, cognition, mobility, pain, nutrition, living environment...)
Sponsors
Centre Hospitalier Universitaire de Saint Etienne
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
80 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* hospitalisation in geriatric unit * Atrial fibrillation treated by anticoagulant treatment (AVK or oral anticoagulation) * signed inform consent
Exclusion criteria
* estimated lifetime less than 6 months * under guardianship or curatorship * without support person
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| scale : standardised geriatric assessment | at baseline | comorbidities, cognition, mobility, pain, nutrition, living environment... |
| scale : shireman | at baseline | gender, age, hemorrhage, diabetes, anemia... |
| scale charlson | at baseline | age, cardiovascular disease, lung disease, neurological disease, endocrinal disease, nephrology, liver disease, gastroenterology, cancer |
| scale : HEMORR2HAGES | at baseline | hepatics diseases, alcoholism, cancer, thrombocytopenia, anemia and antecedent... |
| scale : HAS-Bled | at baseline | arterial hypertension, renal function, liver function, cerebrovascular accident... |
| scale : ATRIA | at baseline | anemia, serious kidney diseases, hypertension, antecedent... |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| genotyping | at baseline | CYP2C9 |
| Occurrence of major bleeding event or not major | at baseline and 6 months | — |
Countries
France
Outcome results
None listed